GOLDMAN SACHS GROUP INC - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 51 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$19,000
-52.5%
14,956
-57.4%
0.00%
Q4 2021$40,000
+122.2%
35,139
+204.1%
0.00%
Q3 2021$18,000
-86.7%
11,555
-83.1%
0.00%
Q2 2021$135,00068,3990.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 189,616$375,439,0001.17%
Ikarian Capital, LLC 1,365,059$2,703,0000.22%
Altium Capital Management LP 446,000$883,0000.20%
ASSET MANAGEMENT CORP /IL/ /ADV 91,500$181,0000.10%
Virtu Financial LLC 113,869$225,0000.02%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 10,000$20,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 155,069$307,0000.01%
McAdam, LLC 55,978$86,0000.01%
Moloney Securities Asset Management, LLC 27,340$54,0000.01%
Allen Capital Group, LLC 23,685$47,0000.01%
View complete list of HEPION PHARMACEUTICALS INC shareholders